Dr. Bharat H. Barai, MD

Media Releases

Get to know Hematologist-Oncologist Dr. Bharat H. Barai, who serves patients in Indiana.

Dr. Barai is regarded as one of the area’s premier physicians in hematology-oncology and has achieved a best-in-class recognition for his medical approach and methodology. He is in practice with Premier Oncology Hematology Associates, seeing patients at the offices in Merrillville and Munster, Indiana.

While he devotes most of his time to personalized patient care, he carves out time for continuing his education at leading medical institutions including Harvard Medical School, the Feinberg School of Medicine at Northwestern University, and the University of California. For over 20 years, he has been committed to educating and training future physicians as an Assistant Professor of Medicine at the Indiana University School of Medicine.

In regards to his educational background, Dr. Barai attended and graduated with his medical degree from Medical College Baroda in India in 1971. He then went on to serve his internship and residency in internal medicine at Advocate Illinois Masonic Medical Center. This was followed by a fellowship in medical hematology at the Feinberg School of Medicine at Northwestern University, and a fellowship in hematology at Rush University Medical Center.

He came to Northwest Indiana from the teaching faculty of Feinberg School of Medicine at Northwestern University in Chicago. He is affiliated with Community Hospital, St. Catherine Hospital in East Chicago, St. Mary Medical Center in Hobart, Franciscan Health Hammond, and Franciscan Health Dyer.

Throughout his extensive career, Dr. Barai has served as the Medical Director of the Cancer Institute at Methodist Hospitals, a member and President of the Medical Licensing Board of the State of Indiana, on the Advisory Board of the Indiana University School of Business, a Trustee and President of FIA Chicago, the Chairman of the Board of Trustees of the Manav Seva Mandir, a Trustee of the Hindu Temple of Greater Chicago, a Trustee of the Indian American Cultural Center NW Indiana, a Voluntary Medical Director of Sickle Cell Foundation of NW Indiana for the Children of Gary, and as the Director of the American Cancer Society, NW Indiana.

Continuously advancing his efforts, he is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the American Medical Association.

With exceptional awareness, sensitivity, and compassion for the finest and most up-to-date scientific care, Dr. Barai is board-certified in internal medicine, hematology, and medical oncology by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of cancer, malignant blood diseases such as leukemia, lymphoma, and multiple myeloma, and blood disorders such as iron-deficiency anemia, clotting abnormalities, hemophilia, and sickle-cell disease.

On a more personal note, Dr. Barai speaks multiple languages, including English, Hindi, Spanish, and Gujarati.

Recommended Articles

• What are the Signs and Symptoms of Lung Cancer?

  Lung cancer is one of the most common cancers in the world. It is a leading cause of cancer death in men and women worldwide. Lung cancer defies classification as a single disease affecting just one organ. The warning signs and painful symptoms represent major systemic disorders in different parts...

• What’s Getting in the Way of Treatment for Rare Types of Ovarian Cancer?

  Women who present to their healthcare provider with acute symptoms often already have progressed ovarian cancer. It is difficult to make medical advances with rare ovarian cancers because there are even fewer patients. Additionally, by the time patients begin to receive treatment, the cancer is...

• What Are the Causes and Symptoms of Peritoneal Cancer?

  Peritoneum refers to the thin tissue lining of the abdominal cavity that protects the organs within the cavity. Fluid produced by the peritoneal tissue keeps the organs moist and allows smooth movement of the organs within the cavity. This epithelial tissue lining covers multiple organs, like...

• Chemotherapy Drugs for Breast Cancer

  What is Chemotherapy?Also called chemo, this is a treatment with cancer killing drugs, which can be given by mouth or intravenously wherein it is injected into the veins. The medication then travels through the bloodstream to reach the cancer cells, which are based on most parts of the body. Not all...

• Chlamydia Doubled Ovarian Cancer Risk, Study Shows

  Chlamydia trachomatis, commonly known as chlamydia, is a type of sexually transmitted infection (STI). In the United States, approximately 1.5 million cases of chlamydia are reported on an annual basis, making it the most commonly reported type of bacterial infection – according to the Centers for...

• Report Finds Primary Care Programs for Cancer Survivors Are Lacking

  ‘Cancer survivor’ is a term that is commonly used in medical literature, where survivorship begins from diagnosis and initial treatment, to cure, cancer-free survival, and long-term follow-up care. Cancer survivors are becoming a fast growing population in the United States. According to the...